Eric Crombez - Apr 21, 2025 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
EVP and Chief Medical Officer
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Apr 21, 2025
Transactions value $
-$28,901
Form type
4
Date filed
5/5/2025, 07:18 PM
Previous filing
Mar 4, 2025
Next filing
Aug 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Crombez Eric EVP and Chief Medical Officer C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO /s/ Karah Parschauer, attorney-in-fact 2025-05-05 0001653052

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$8.5K -242 -0.34% $35.11 71.7K Apr 21, 2025 Direct F1
transaction RARE Common Stock Sale -$20.4K -520 -0.72% $39.24 71.5K May 5, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
F2 Includes 370 shares acquired on April 30, 2025 under the Company's Amended and Restated Employee Stock Purchase Plan
F3 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.